Norges Bank Decibel Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$6.6 - $9.04 $99,000 - $135,600	-15,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$6.39 - $11.51 $95,850 - $172,650	15,000 New	15,000 $129,000
Q2 2021 Aug 10, 2021	SELL	$6.39 - $11.51 $95,850 - $172,650	-15,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$10.56 - $19.9 $158,400 - $298,500	15,000 New	15,000 $170,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.